Evidence map›Paper›PMID 40452936›Full record

ArticlePeerJ2025

Gene expression profiling of extraocular muscles in primary inferior oblique overaction.

Rui Hao, Yuchuan Wang, Wei Zhang

Abstract read
In one paragraph

Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rui Hao *Tianjin Eye Hospital, Tianjin, China.
Yuchuan Wang *Tianjin Eye Hospital, Tianjin, China.
Wei ZhangTianjin Eye Hospital, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study investigates gene expression differences in primary inferior oblique overaction (IOOA) by performing transcriptome sequencing on extraocular muscles (EOMs) from patients with primary and secondary IOOA. Strabismus, particularly IOOA, is often associated with abnormal eye movement due to imbalanced muscle function. By using bioinformatic analyses to identify differentially expressed genes (DEGs) and enriched pathways, we aim to uncover the molecular distinctions that may underlie the unique neuromuscular characteristics of primary IOOA. Methods: Transcriptome sequencing was conducted on EOMs from ten patients with primary IOOA and ten patients with secondary IOOA. DEGs were identified using DESeq2. Gene Ontology (GO) annotations were enriched using ClusterProfiler and GlueGo, and the overall gene expression data were analyzed with Gene Set Enrichment Analysis (GSEA). The protein-protein interaction (PPI) network of DEGs was constructed using STRING. Results: We identified 258 DEGs, with 110 genes significantly upregulated and 148 genes downregulated in the primary IOOA group compared to the secondary IOOA group. Analysis of DEGs revealed that upregulated genes in the primary group were associated with myelination ( Conclusion: Our preliminary findings suggested that neuromuscular DEGs in primary IOOA were enriched in pathways related to myelination, ion channels, M-bands, and collagen fibril. The results indicated that multiply innervated muscle fibers were more abundant in the primary IOOA group, likely enabling slow tension generation, whereas the secondary IOOA group exhibited higher collagen fibril levels that might improve muscle stiffness.

Indexed as

Gene Expression ProfilingOculomotor MusclesStrabismusAdultChildChild, PreschoolComputational BiologyFemaleGene OntologyHumansMaleProtein Interaction MapsTranscriptomeExtraocular musclesGene expressionInferior oblique overactionTranscriptomics

Identifiers

PMID40452936
PMCPMC12126087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.